Isea de la Viña, JesúsOrtega Granados, Ana LauraAlcázar-Navarrete, Bernardino2023-02-082023-02-082020-03-31http://hdl.handle.net/10668/15436enAge FactorsAntineoplastic AgentsBetacoronavirusCOVID-19Carcinoma, BronchogenicCombined Modality TherapyComorbidityCoronavirus InfectionsCritical CareDisease ManagementHospital MortalityHumansLung NeoplasmsPandemicsPneumonectomyPneumonia, ViralPrognosisRetrospective StudiesRiskSARS-CoV-2Time-to-TreatmentSARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context.Situación clínica de infección por SARS-CoV-2 en pacientes con carcinoma broncogénico: contexto actual.research article32336565open access10.1016/j.arbres.2020.03.0182173-5751PMC7270581https://doi.org/10.1016/j.arbres.2020.03.018https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270581/pdf